Enhancement of hyperthermia-induced apoptosis by local anesthetics on human histiocytic lymphoma U937 cells
/in Hyperthermia, International Publications, Malignant Lymphoma /von 2002-02-22 / J. Biol. Chem. 2002 May;277(21):18986-93Novel target antigens for dendritic cell-based immunotherapy against ovarian cancer
/in International Publications, Ovarian Cancer /von 2002-02-01 / Expert Rev Anticancer Ther 2002 Feb;2(1):97-105Idiotype protein-pulsed dendritic cells produce strong anti-myeloma effects after syngeneic stem cell transplantation in mice
/in Dendritic Cells, International Publications, Multiple Myeloma /von 2002-02-01 / Bone Marrow Transplant. 2002 Feb;29(3):213-21Generation of dendritic cells from human bone marrow mononuclear cells: advantages for clinical application in comparison to peripheral blood monocyte derived cells
/in Dendritic Cells, International Publications /von 2002-02-01 / Int. J. Oncol. 2002 Feb;20(2):247-53
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution